Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Biomarker-testing mandate debated in Ohio House Health Committee; amendment adopted to track use and costs
Summary
House Bill 8 would require health plans and Medicaid to cover biomarker testing; the committee adopted an amendment requiring annual reporting on tests and costs, while proponents cited life-saving cases and opponents warned of premium increases and gaps for self-insured plans.
House Bill 8, which would require coverage of biomarker testing by health plans and Medicaid, prompted sharply divided committee testimony on whether mandated coverage is a clinical necessity or a cost risk for employers and insurers.
Dr. Barbara Marsh of the Lung Cancer Research Foundation, a proponent, told members her husband faced treatment delays after an insurer denied biomarker testing, describing a process that involved three biopsies and appeals before Ohio State clinicians obtained results…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
